In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Denis Arsenault,
Manager of Policy Development
| Health Products and Food Branch
|
Health Canada (HC)
-
Pui Wai Yuen,
Director
| Uranium and Radioactive Waste Division
|
Natural Resources Canada (NRCan)
-
Mary Boreskie,
Sector Analyst
| Life Sciences Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
-
Samir Khan,
Director
| Office of Pharmaceuticals Management
|
Health Canada (HC)
-
Mitchell Rowe,
Senior Policy Analyst
| Office of Pharmaceuticals Management
|
Health Canada (HC)
-
Dr. Michael Rosu-Myles,
Director
| Biological and Radiopharmaceutical Drugs
|
Health Canada (HC)
-
Raphael Galea,
Team Leader
| Metrology
|
National Research Council (NRC)
-
Malcolm McEwen,
Director, Research and Development
| Energy, Mining, and Environment
|
National Research Council (NRC)
-
Tess Wittman,
Policy Analyst
| Uranium and Radioactive Waste Division
|
Natural Resources Canada (NRCan)
-
Kate Prosser,
Policy Advisor
| Uranium and Radioactive Waste Division
|
Natural Resources Canada (NRCan)
-
Frédéric Beauregard-Tellier,
Director General
| Nuclear Energy and Infrastructure Security Branch
|
Natural Resources Canada (NRCan)
-
Rodrigo Arancibia,
Director, Life Sciences
| Office of Life Sciences and Biomanufacturing Readiness
|
Innovation, Science and Economic Development Canada (ISED)
-
Cameron Christensen,
Senior Investment Analyst
| Collaborations and Net Office of Life Sciences and Biomanufacturing Readiness
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Energy,
Research and Development,
Health
Communication date:
2024-03-26
Posted date:
2024-04-15
Communication number:
5776-599794
View associated registration